Delivery Order SPE2DE21D7010-SPE2D625F9L6L
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $5,189.76 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 2, 2025. The contract, designated as "SMALL INTERLOCK II," represents a fixed-price delivery order with economic price adjustment mechanisms and carries an ultimate completion date of September 22, 2025. The award was made without any set-aside designation,...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products, was awarded a $16,854 delivery order contract by the Defense Logistics Agency (DLA) Medical Supply Chain on April 30, 2025. This fixed-price contract with economic price adjustment provisions is classified as a delivery order with no set-aside designation, reflecting Nuvasive's competitive success in open market procurements. The contract is scheduled for completion by May 1, 2025, and will be...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and technologies, was awarded a delivery order valued at $8,533.00 by the Defense Logistics Agency (DLA) Medical Supply Chain on August 14, 2025. This fixed-price delivery order with economic price adjustment mechanism does not utilize any set-aside designation, indicating the contract was awarded through open market competition. The contract is scheduled for completion by August 15, 2025, and...
- Nuvasive, Inc., a leading supplier of specialized spinal medical devices and surgical technologies, was awarded a fixed-price delivery order valued at $3,472.90 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 23, 2025. The contract, which carries no set-aside designation, will be performed in San Diego, California, and includes an economic price adjustment mechanism to account for potential cost fluctuations. This...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and services, received a delivery order award valued at $1,850.60 from the Defense Logistics Agency (DLA) Medical Supply Chain on July 17, 2025. The contract, designated as a fixed-price agreement with economic price adjustment mechanisms, carries an ultimate completion date of August 6, 2025. This award was issued without set-aside designation, indicating open market competition. The delivery...
- Nuvasive, Inc. was awarded a $21,488.67 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency, on April 29, 2025. The delivery order, which is not set-aside designated, requires completion by May 19, 2025, and will be performed in San Diego, California. As a leading medical device manufacturer specializing in spinal surgery products, Nuvasive supplies advanced spinal implants, fusion devices,...
- Nuvasive, Inc. was awarded a delivery order valued at $1,041.87 by the Defense Logistics Agency (DLA) Medical Supply Chain on April 23, 2025, with an ultimate completion date of May 13, 2025. The contract, which carries no set-aside designation, utilizes fixed-price pricing with economic price adjustment mechanisms and will be performed in San Diego, California. As a leading medical device manufacturer specializing in spinal surgery products, Nuvasive will deliver specialized medical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a $13,877.52 fixed-price delivery order (Contract No. 4569002143) by the Defense Logistics Agency Medical Supply Chain on August 4, 2025. The delivery order, designated "SMALL INTERLOCK II," includes economic price adjustment provisions and calls for performance in San Diego, California, with an ultimate completion date of August 5, 2025. This award was made without...
- Nuvasive, Inc. was awarded a $9,368 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain on August 13, 2025, with an ultimate completion date of September 3, 2025. This fixed-price contract with economic price adjustment mechanisms represents a non-competitive procurement with no set-aside designation. Nuvasive, a San Diego-based medical device company specializing in spinal surgery products and services, will deliver advanced spinal medical technologies, implants, and...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $1,590 on June 25, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as a fixed-price agreement with economic price adjustment provisions, calls for delivery of an ACP Hybrid System and is scheduled for completion by July 17, 2025. This award was issued without set-aside designations, indicating open market competition....
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D625F9L6LDelivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $5,189.76 on May 28, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as delivery order 4568393753 for the SMALL INTERLOCK II product, is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of June 17, 2025. This award was made without any set-aside designation, indicating that Nuvasive competed successfully in an open market procurement environment. As a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, Nuvasive continues its established role as a key supplier of advanced spinal medical technologies to federal healthcare agencies, including the Department of Defense and Veterans Affairs. This delivery order likely represents a task order issued under Nuvasive's broader Indefinite Delivery/Indefinite Quantity blanket purchase agreement with the Defense Health Agency, valued at $8 million and effective through March 2027. The company's extensive federal contract portfolio reflects its consistent ability to provide specialized spinal implants, instruments, and surgical devices to support complex orthopedic and neurological procedures across the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 5/28/25 |